Neumora Therapeutics (NMRA) Times Interest Earned (2022 - 2026)

Neumora Therapeutics' Times Interest Earned history runs 5 years deep, the most recent figure standing at -$28.51 for Q1 2026.

• On a quarterly basis, Times Interest Earned changed N/A year-over-year to -$28.51 in Q1 2026; TTM through Mar 2026 was -$57.35, a N/A change from a year earlier, with the FY2025 full-year figure at -$0.73, up 26.71% from the prior year.
• Times Interest Earned climbed to -$28.51 in Q1 2026 per NMRA's latest filing, from -$28.72 in the prior quarter.
• Across five years, Times Interest Earned topped out at -$0.22 in Q4 2022 and bottomed at -$57.7 in Q3 2025.
• The 5-year median for Times Interest Earned is -$1.26 (2024), against an average of -$16.87.
• Across the five-year window, Times Interest Earned slumped 110.35% in 2024 and sank 5392.29% in 2025, its largest moves.
• Year by year, Times Interest Earned stood at -$0.22 in 2022, then sank by 257.47% to -$0.78 in 2023, then tumbled by 35.43% to -$1.05 in 2024, then sank by 2634.05% to -$28.72 in 2025, then rose by 0.73% to -$28.51 in 2026.
• Per Business Quant, the three latest NMRA Times Interest Earned figures stand at -$28.51 (Q1 2026), -$28.72 (Q4 2025), and -$57.7 (Q3 2025).